UAB Lung Health Center

Birmingham, Alabama 35294

5 studies enrolling now · 19 studies all time

What they study most

Arsenic and/or Arsenic Compound Adverse Reaction, Asthma, COPD, Chronic Bronchitis, Chronic Disease, Chronic Obstructive Pulmonary Disease, Covid19, Diastolic Dysfunction, Emphysema, Hereditary Angioedema, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)

Studies at this site

• A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting now
• A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis — Recruiting now
• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
• Housing, Environment, And Living Conditions for Transformed Health — Recruiting now
• Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation — Enrolling by invitation
• Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection — Completed
• The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor — Completed
• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies — Completed
• A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients — Completed
• Acthar Gel in Participants With Pulmonary Sarcoidosis — Completed
• COVID-19 Study of Safety and Tolerability of Alvelestat — Completed
• Smart Telehealth Exercise Intervention to Reduce COPD Readmissions — Completed
• Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD — Completed
• A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) — Completed
• Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects — Completed
• Dose Finding Study in COPD — Completed
• Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema — Stopped early
• A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD) — Completed